Aarti Pharmalabs Limited
AARTIPHARM

Aarti Pharmalabs Limited

Pharmaceuticals
Share price
₹991
Market cap
₹8,975 Cr
1Y return
▲ 40%

A pharmaceutical and nutraceutical manufacturer, Aarti Pharmalabs produces active pharmaceutical ingredients and finished dosage forms for domestic and international markets. The company specializes in contract manufacturing and custom synthesis services across multiple therapeutic segments including oncology, cardiology, and gastroenterology. Incorporated in 2019, it operates manufacturing facilities designed to meet stringent regulatory standards for pharmaceutical production and quality assurance.

Investors holding Aarti Pharmalabs Limited

LIC
LIC
Institution
4.72%

Recent moves 11

Moves11
LICDecreased
LIC cut its stake in Aarti Pharmalabs from 5.27% to 4.72%, selling 5,00,000 shares. This transaction took its total holding down to 42,82,452 shares, slipping below the 5% regulatory disclosure threshold.
17 Oct 2026
Read more
GLOIRE TRUSTEESHIP SERVICES PVT. LTD. (LOTUS FAMILY TRUST)Decreased
The promoter group of Aarti Pharmalabs, led by Gloire Trusteeship Services (Lotus Family Trust), cut its stake from 42.88% to 39.66%, selling 29,02,975 shares through the open market. Gloire Trusteeship Services Pvt Ltd (Lotus Family Trust) - 6,24,500 shares
21 Sept 2026
Read more
RAJENDRA VALLABHAJI GOGRIDecreased
Promoter Rajendra Vallabhaji Gogri sold 3,88,725 shares of Aarti Pharmalabs for ₹31.83 Cr at ₹818.77 apiece in the open market, reducing his stake from 1.57% to 1.14%.
21 Sept 2026
Read more
Gloire Trusteeship Services Private LimitedExited
Gloire Trusteeship Services Private Limited sold 3,97,500 shares of Aarti Pharmalabs Limited for ₹32.55 Cr at ₹818.77 apiece, resulting in a full exit from the company.
21 Sept 2026
Read more
Relacion Trusteeship Services Private LimitedExited
Relacion Trusteeship Services Private Limited sold 3.8 lakh shares of Aarti Pharmalabs Limited for ₹31.12 Cr at ₹818.83 apiece through an open market sale, resulting in a full exit.
21 Sept 2026
Read more
ARTI RAJENDRA GOGRIDecreased
Arti Rajendra Gogri sold 1,33,564 shares of Aarti Pharmalabs for ₹10.94 Cr at ₹818.77 apiece in an open-market sale, reducing their stake from 0.50% to 0.35%.
21 Sept 2026
Read more
Relacion Trusteeship Services Private LimitedExited
Relacion Trusteeship Services Private Limited sold 6.27 lakh shares of Aarti Pharmalabs Limited for ₹51.38 Cr at ₹818.79 apiece, completely exiting its stake via a market sale.
18 Sept 2026
Read more
Relacion Trusteeship Services Private Limited and Gloire Trusteeship Services Private LimitedExited
Relacion Trusteeship Services Private Limited and Gloire Trusteeship Services Private Limited sold 12,52,000 shares of Aarti Pharmalabs for ₹102.52 Cr at ₹818.79 apiece through an open market sale. This transaction marks a full exit from their holding in the company.
18 Sept 2026
Read more
Unifi CapitalNew position
PMS fund manager Unifi Capital bought 9.15 lakh shares of Aarti Pharmalabs for ₹75.03 Cr through a bulk deal on the NSE at ₹820 apiece.
21 Sept 2026
Read more
Relacion Trusteeship Services Private Limited and Safechem Enterprises Private LimitedDecreased
Relacion Trusteeship Services Private Limited and Safechem Enterprises Private Limited sold 1,19,400 shares of Aarti Pharmalabs Limited for ₹10.43 Cr at ₹871.08 apiece, reducing their promoter group stake from 0.76% to 0.69%.
8 Sept 2026
Read more

Track the whales in Aarti Pharmalabs Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1